MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.soard.2026.02.019

Медицинская библиотека · Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2026

Efficacy of preoperative GLP-1 receptor agonists on the perioperative outcomes of bariatric surgery: a systematic review and meta-analysis.

Liu Chenming, Tian Peirong, Li Mengyi, Liu Yang, Liu Jingli, Zhang Zhongtao, Zhang Peng

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

BACKGROUND

The perioperative effect of preoperative administration of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in individuals with obesity scheduled to receive metabolic and bariatric surgery (MBS) remains uncertain.

OBJECTIVES

The objective of this systematic review and meta-analysis was to evaluate the efficacy of preoperative GLP-1 RAs in patients with obesity undergoing MBS.

SETTING

All over the world.

METHODS

Original studies were searched from the inception of PubMed, Embase, and Web of Science up to September 2025. Primary outcomes were the variation of weight from the initial to the preoperative period and postoperative total weight loss percentage (TWL%). Secondary outcomes included the incidence of postoperative complications, postoperative glycated hemoglobin level, and the proportion of patients with remission of diabetes.

RESULTS

After screening, 10 studies consisting of 5461 subjects were included in the final meta-analysis. The results showed that preoperative GLP-1 RAs were associated with a moderate reduction in preoperative weight (total median of weight reduction: 4.87 kg vs 3.84 kg; SMD: .4, 95% CI: -.37 to 1.18, P < .01) but did not significantly affect postoperative TWL% (SMD: -.20, 95% CI: -.27 to -.13, P = .21). Preoperative administration of GLP-1 RAs did not significantly increase the incidence of postoperative complications (RR: 1.62, 95% CI: .76-3.45, P = .12) nor improve the comorbidities (P = .23).

CONCLUSIONS

Our study indicates that preoperative GLP-1 RAs are generally safe for patients with obesity undergoing MBS. However, this benefit only correlates with a certain degree of preoperative weight loss, and its effect on postoperative weight loss and improvement of comorbidities are limited.

Для цитирования: Liu Chenming, Tian Peirong, Li Mengyi, Liu Yang, Liu Jingli, Zhang Zhongtao, Zhang Peng. Efficacy of preoperative GLP-1 receptor agonists on the perioperative outcomes of bariatric surgery: a systematic review and meta-analysis.. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2026. DOI: 10.1016/j.soard.2026.02.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.